CRF-RI Polyclonal Antibody

CRH encodes a member of the corticotropin-releasing factor family. The encoded preproprotein is proteolytically processed to generate the mature neuropeptide hormone. In response to stress, this hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus, binds to corticotropin releasing hormone receptors and stimulates the release of adrenocorticotropic hormone from the pituitary gland. Marked reduction in this protein has been observed in association with Alzheimer's disease. Autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes, and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition.

Introducing the CRF-RI Polyclonal Antibody, a cutting-edge product designed to revolutionize the field of immunology. This meticulously crafted antibody is specifically engineered to target and detect the Corticotropin-Releasing Factor Receptor I (CRF-RI), a crucial protein involved in stress response and regulation.

The CRF-RI Polyclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in various experimental settings. Its high affinity for CRF-RI enables precise identification and quantification of this vital receptor, facilitating comprehensive investigations into its functional role and potential therapeutic applications.

Crafted with utmost precision and utilizing state-of-the-art techniques, this antibody exhibits exceptional performance across a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Its versatility allows for seamless integration into diverse research methodologies, empowering scientists and researchers to delve deeper into the intricate mechanisms underlying stress-related disorders.

Furthermore, the CRF-RI Polyclonal Antibody is meticulously validated through rigorous quality control measures, ensuring consistent and reproducible results. Its exceptional stability and long shelf life guarantee optimal performance, making it an indispensable tool for both academic and industrial laboratories.

In summary, the CRF-RI Polyclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the understanding and treatment of stress-related disorders. Embrace the future of immunology with the CRF-RI Polyclonal Antibody and unlock new frontiers in scientific exploration.